KUALA LUMPUR: CCM Duopharma Biotech Bhd has bought a 5.8% stake in South Korea’s SCM Lifescience Co, Ltd, which specialises in stem cell therapeutics, for RM20.24mil.

CCM Duopharma, which develops generic drugs and branded healthcare products, said this marked its foray into regenerative medicine.

It also entered into an exclusive marketing and commercialisation deal with SCM. It acquired the rights to market and commercialise products developed by SCM in selected Asean countries.

SCM specialises in stem cell therapeutics with proprietary platform technology in the field of high-purity isolation and cultivation of mesenchymal stem cells.

...

Full Article on TheStar